PT Kimia Farma (Persero) Tbk (KAEF):企業の財務・戦略的SWOT分析

◆英語タイトル:PT Kimia Farma (Persero) Tbk (KAEF) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C7723
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:37
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:インドネシア
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

PT Kimia Farma (Persero) Tbk (KAEF) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

PT Kimia Farma (Persero) Tbk (Kimia Farma) manufactures, commercializes and distributes pharmaceutical products. The company provides ethical (prescription), generic and other products. It offers products in various categories including alimentary system, allergy and immune system, system anaesthetic, local and general antibiotic, antidotes and detoxifying, cardiovascular and hematopoietic, dermatological, eye and ear, genito – urinary system, hormones, intravenous and other sterile, metabolism, neuromuscular, other chemoterapetics, respiratory, vitamin and minerals and others. Kimia Farma distributes its products in various countries across the world including Asia, Europe and Africa. The company operates manufacturing plants in Jakarta, Bandung, Semarang, Watudakon, Medan and West Java. Kimia Farma is headquartered in Jakarta, Indonesia.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Section 1 – About the Company 6
PT Kimia Farma (Persero) Tbk – Key Facts 6
PT Kimia Farma (Persero) Tbk – Key Employees 7
PT Kimia Farma (Persero) Tbk – Major Products and Services 8
PT Kimia Farma (Persero) Tbk – History 9
PT Kimia Farma (Persero) Tbk – Company Statement 11
PT Kimia Farma (Persero) Tbk – Locations And Subsidiaries 12
Head Office 12
Other Locations & Subsidiaries 12
Joint Venture 13
Section 2 – Company Analysis 14
Company Overview 14
PT Kimia Farma (Persero) Tbk – Business Description 15
Business Segment: Distribution Segment 15
Overview 15
Performance 15
Business Segment: Manufacturing Segment 15
Overview 15
Performance 15
Business Segment: Other Segment 16
Performance 16
Business Segment: Retail Segment 16
Overview 16
Performance 16
R&D Overview 16
PT Kimia Farma (Persero) Tbk – Corporate Strategy 17
PT Kimia Farma (Persero) Tbk – SWOT Analysis 18
SWOT Analysis – Overview 18
PT Kimia Farma (Persero) Tbk – Strengths 18
PT Kimia Farma (Persero) Tbk – Weaknesses 19
PT Kimia Farma (Persero) Tbk – Opportunities 20
PT Kimia Farma (Persero) Tbk – Threats 21
PT Kimia Farma (Persero) Tbk – Key Competitors 22
Section 3 – Company Financial Ratios 23
Financial Ratios – Capital Market Ratios 23
Financial Ratios – Annual Ratios 24
Performance Chart 27
Financial Performance 27
Financial Ratios – Interim Ratios 28
Financial Ratios – Ratio Charts 29
Section 4 – Company’s Lifesciences Financial Deals and Alliances 30
PT Kimia Farma (Persero) Tbk, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 30
PT Kimia Farma (Persero) Tbk, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 31
PT Kimia Farma (Persero) Tbk, Recent Deals Summary 32
Section 5 – Appendix 33
Methodology 33
Ratio Definitions 33
About GlobalData 37
Contact Us 37
Disclaimer 37

List of Tables
PT Kimia Farma (Persero) Tbk, Key Facts 6
PT Kimia Farma (Persero) Tbk, Key Employees 7
PT Kimia Farma (Persero) Tbk, Major Products and Services 8
PT Kimia Farma (Persero) Tbk, History 9
PT Kimia Farma (Persero) Tbk, Other Locations 12
PT Kimia Farma (Persero) Tbk, Subsidiaries 12
PT Kimia Farma (Persero) Tbk, Joint Venture 13
PT Kimia Farma (Persero) Tbk, Key Competitors 22
PT Kimia Farma (Persero) Tbk, Ratios based on current share price 23
PT Kimia Farma (Persero) Tbk, Annual Ratios 24
PT Kimia Farma (Persero) Tbk, Annual Ratios (Cont...1) 25
PT Kimia Farma (Persero) Tbk, Annual Ratios (Cont...2) 26
PT Kimia Farma (Persero) Tbk, Interim Ratios 28
PT Kimia Farma (Persero) Tbk, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 30
PT Kimia Farma (Persero) Tbk, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 31
PT Kimia Farma (Persero) Tbk, Recent Deals Summary 32
Currency Codes 33
Capital Market Ratios 33
Equity Ratios 34
Profitability Ratios 34
Cost Ratios 35
Liquidity Ratios 35
Leverage Ratios 36
Efficiency Ratios 36

List of Figures
PT Kimia Farma (Persero) Tbk, Performance Chart (2013 - 2017) 27
PT Kimia Farma (Persero) Tbk, Ratio Charts 29
PT Kimia Farma (Persero) Tbk, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 30
PT Kimia Farma (Persero) Tbk, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 31

★海外企業調査レポート[PT Kimia Farma (Persero) Tbk (KAEF):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Sygnis AG (LIO1)-医療機器分野:企業M&A・提携分析
    Summary Sygnis AG (Sygnis), formerly Sygnis Pharma AG is a biopharmaceutical company that develops novel products and tools in fields of molecular biology. The company undertakes development and marketing of new molecular biological technologies for DNA amplification and sequencing. Its products inc …
  • 21st Century Oncology Inc:企業の戦略的SWOT分析
    21st Century Oncology Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Eagle Energy Inc (EGL):石油・ガス:M&Aディール及び事業提携情報
    Summary Eagle Energy Inc (Eagle) is an oil and gas company that acquires for, develops and produces oil and gas reserves through its subsidiaries. It focuses on the acquisition and exploitation of conventional long-life hydrocarbon reserves in on-shore production basins in North America. It acquires …
  • New Silkroad Culturaltainment Limited.:企業の戦略・SWOT・財務分析
    New Silkroad Culturaltainment Limited. - Strategy, SWOT and Corporate Finance Report Summary New Silkroad Culturaltainment Limited. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT ana …
  • Clarivate Plc (CLVT):企業の財務・戦略的SWOT分析
    Clarivate Plc (CLVT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Asahi Kasei Corporation:企業の戦略・SWOT・財務情報
    Asahi Kasei Corporation - Strategy, SWOT and Corporate Finance Report Summary Asahi Kasei Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Deutsche Telekom AG:企業の戦略・SWOT・財務情報
    Deutsche Telekom AG - Strategy, SWOT and Corporate Finance Report Summary Deutsche Telekom AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Shree Cement Limited:企業の戦略・SWOT・財務情報
    Shree Cement Limited - Strategy, SWOT and Corporate Finance Report Summary Shree Cement Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Medicenna Therapeutics Corp (MDNA):製薬・医療:M&Aディール及び事業提携情報
    Summary Medicenna Therapeutics Corp (Medicenna), formerly A2 Acquisition Corp, is a clinical stage immuno-oncology company. The company develops empowered cytokines (EC) and superkines for the treatment of cancer. Its pipeline products include MDNA55, MDNA109, MDNA209, MDNA57, MDNA413, and MDNA132. …
  • Turkish Aerospace Industries Inc:企業の戦略・SWOT・財務分析
    Turkish Aerospace Industries Inc - Strategy, SWOT and Corporate Finance Report Summary Turkish Aerospace Industries Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Event Hospitality & Entertainment Ltd:企業の戦略・SWOT・財務分析
    Event Hospitality & Entertainment Ltd - Strategy, SWOT and Corporate Finance Report Summary Event Hospitality & Entertainment Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • Camber Energy Inc (CEI):石油・ガス:M&Aディール及び事業提携情報
    Summary Camber Energy Inc (Camber Energy), formerly known as Lucas Energy, Inc., is an independent oil and gas company. It explores, develops, and produces crude oil, natural gas and natural gas liquids (NGL). The company has asset base in Texas and Oklahoma. Its producing fields include Lincoln, Lo …
  • Range Resources Ltd (RRS):石油・ガス:M&Aディール及び事業提携情報
    Summary Range Resources Ltd (Range Resources) is an independent upstream oil and gas company. It explores, develops and produces oil and gas in Georgia, Guatemala and Trinidad. The company works on both onshore and offshore production and its onshore projects are operational through water injection. …
  • Shimano Inc (7309):企業の財務・戦略的SWOT分析
    Shimano Inc (7309) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Dai Nippon Printing Co Ltd (7912):企業の財務・戦略的SWOT分析
    Dai Nippon Printing Co Ltd (7912) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Sigma-Tau HealthScience USA, Inc:企業の戦略・SWOT・財務情報
    Sigma-Tau HealthScience USA, Inc - Strategy, SWOT and Corporate Finance Report Summary Sigma-Tau HealthScience USA, Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Strongbridge Biopharma plc (SBBP)-製薬・医療分野:企業M&A・提携分析
    Summary Strongbridge Biopharma plc (Strongbridge), formerly Cortendo plc, is a commercial-stage biopharmaceutical company that develops and commercializes therapies for rare diseases. The company’s marketed product, KEVEYIS (dichlorphenamide), is indicated for the treatment of hyperkalemic, hypokale …
  • Applied Industrial Technologies, Inc.:企業の戦略・SWOT・財務分析
    Applied Industrial Technologies, Inc. - Strategy, SWOT and Corporate Finance Report Summary Applied Industrial Technologies, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • Ten Network Holdings Ltd:企業の戦略的SWOT分析
    Ten Network Holdings Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • GLG Life Tech Corp (GLG):企業の財務・戦略的SWOT分析
    GLG Life Tech Corp (GLG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆